Wanshen Guo

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2020 · 1.2K citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +5

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes

Shengli Xia, Kai Duan, Yuntao Zhang et al. · JAMA · 2020 · 793 citations · Full text

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2021 · 198 citations · Full text

Molecular Characterization and Antimicrobial Susceptibility of <i>Salmonella</i> Isolates from Infections in Humans in Henan Province, China

Shengli Xia, René S. Hendriksen, Zhiqiang Xie et al. · Journal of Clinical Microbiology · 2008 · 107 citations · Full text

Molecular Epidemiology, Microbial Pathogens, Pathogen Detection +19

Emergence and Transmission Pathways of Rapidly Evolving Evolutionary Branch C4a Strains of Human Enterovirus 71 in the Central Plain of China

Yong Zhang, Ji‐Tao Wang, Wanshen Guo et al. · PLoS ONE · 2011 · 94 citations · Full text